pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CAR-T · news · pharmadog
← back to CAR-T
News · CAR-T
190
stories
Oct 7, 26
STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
stat
Oct 7, 26
Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
biospace
Oct 7, 26
Updated: CAR-T biotech Caribou to pull the plug after struggling to find funding
endpoints
Oct 7, 26
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
stat
Oct 6, 26
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
fiercebiotech
Oct 5, 26
Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
biospace
Oct 5, 26
Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
biospace
Oct 2, 26
Novartis wagers almost $8B on a Chinese biotech’s RNA drugs
biopharma dive
Oct 2, 26
Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager
fiercebiotech
Oct 1, 26
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
Oct 1, 26
Trump administration appeals ruling blocking limits on international student visas
stat
Sep 30, 26
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
Sep 29, 26
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
stat
Sep 29, 26
Spark co-founder Steven Altschuler is back with an immune-resetting biotech
endpoints
Sep 28, 26
Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway
endpoints
Sep 28, 26
An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus
biopharma dive
Sep 28, 26
Scynexis' BARDA alliance; Bristol Myers' early data for dual-targeting CAR-T
endpoints
Sep 25, 26
Endpoints 11 2026 winner Azalea melds gene editing and CAR-T
endpoints
Sep 25, 26
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
fiercebiotech
Sep 25, 26
J&J, Legend tout long-term survival benefits for Carvykti in multiple myeloma
biospace
Sep 24, 26
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data
biospace
Sep 24, 26
Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
endpoints
Sep 23, 26
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
fiercebiotech
Sep 23, 26
‘It’s certainly not easy’: How are Boston biotechs coping with a shallower pool of seed funding?
fiercebiotech
Sep 23, 26
9 companies hiring in Pennsylvania now
biospace
Sep 17, 26
Cellares and Ori Biotech’s new cell therapy manufacturing contracts
endpoints
Sep 17, 26
Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
fiercebiotech
Sep 17, 26
Webinar: Manufacturing in Turbulent Times
biospace
Sep 16, 26
Novartis ends ALS program after phase 2 flop, adding to R&D woes
fiercebiotech
Sep 15, 26
Blood centers can help biopharma scale cell and gene therapies
biospace
← prev
page 3 of 7
next →